Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non–small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|18|3367-3376

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.18, 2013-09, pp. : 3367-3376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations

By  

Oncology, Vol. 89, Iss. 5, 2015-0 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite